Showing results (51-60 of 265) with videos related to
Sort By:
Pageof 27
The Journal of Antimicrobial Chemotherapy|February 14, 2004
Immunosuppressive drugs as an adjuvant to HIV treatmentEmilio Fumero, Felipe García, J M GatellMedicina Clinica|February 12, 1998
[Direct pharmaceutical costs, diagnostic related groups and CD4 cell count in hospitalized HIV-infected patients]J Serrais, J Mallolas, J RibasHIV Medicine|April 28, 2007
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical areaE Martínez, A Milinkovic, E Buira, et al.Medicina Cutanea Ibero-Latino-Americana|January 1, 1980
[Postovulation dermatitis (dermatitis caused by progesterone)]H Torras, J Ferrando, J MallolasHIV Medicine|March 28, 2008
Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell countsE De Lazzari, A León, J A Arnaiz, et al.HIV Medicine|October 24, 2012
Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studiesM Calvo-Sánchez, R Perelló, I Pérez, et al.HIV Medicine|May 11, 2018
Subclinical cardiovascular disease in patients starting contemporary protease inhibitorsA González-Cordón, M Doménech, M Camafort, et al.HIV Medicine|February 4, 2009
Objective amount of limb fat in HIV-infected subjects with subjective diagnosis of lipoatrophyE Martínez, M Larrousse, D Podzamczer, et al.AIDS (London, England)|June 27, 2001
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapyE Martínez, J L Blanco, J A Arnaiz, et al.Pageof 27